Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials
出版年份 2019 全文链接
标题
Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials
作者
关键词
-
出版物
ACTA PSYCHIATRICA SCANDINAVICA
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-03-05
DOI
10.1111/acps.13016
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
- (2018) Andrea Cipriani et al. LANCET
- Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence – A Danish nationwide study
- (2018) Brian Villumsen Broberg et al. SCHIZOPHRENIA RESEARCH
- Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial
- (2017) Muhammad I Husain et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
- (2017) Dennis Chan et al. LANCET NEUROLOGY
- Efficacy and safety of celecoxib monotherapy for mild to moderate depression in patients with colorectal cancer: A randomized double-blind, placebo controlled trial
- (2017) Maryam Alamdarsaravi et al. PSYCHIATRY RESEARCH
- Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies
- (2017) Christopher E.M. Griffiths et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- The Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study
- (2016) Ole Köhler et al. AMERICAN JOURNAL OF PSYCHIATRY
- Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
- (2016) Ole Kohler et al. Current Neuropharmacology
- Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients
- (2016) Hamid Emadi-Kouchak et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A randomised, double-blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia
- (2016) H. Mahagna et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials
- (2016) Estela Salagre et al. JOURNAL OF AFFECTIVE DISORDERS
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
- (2016) N Kappelmann et al. MOLECULAR PSYCHIATRY
- Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report
- (2016) Sriram Yennurajalingam et al. ONCOLOGIST
- Inflammation and Specific Symptoms of Depression
- (2016) Markus Jokela et al. JAMA Psychiatry
- Telomere length as a predictor of response to Pioglitazone in patients with unremitted depression: a preliminary study
- (2016) N Rasgon et al. Translational Psychiatry
- Inflammation and clinical response to treatment in depression: A meta-analysis
- (2015) R. Strawbridge et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial
- (2015) S. Jafari et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial
- (2015) Amirhossein Gougol et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response
- (2015) Kathleen Watson Lin et al. PSYCHIATRY RESEARCH
- An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
- (2014) Rudolf Uher et al. AMERICAN JOURNAL OF PSYCHIATRY
- In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder
- (2014) Mohammad Haghighi et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
- (2014) Ole Köhler et al. JAMA Psychiatry
- NSAIDs Are Associated with Lower Depression Scores in Patients with Osteoarthritis
- (2013) Rupa L. Iyengar et al. AMERICAN JOURNAL OF MEDICINE
- Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor- Inhibitors: Systematic Review of the Literature
- (2013) S. S. Toussi et al. CLINICAL INFECTIOUS DISEASES
- AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED-CLINICAL TRIAL
- (2013) Ahmad Ghanizadeh et al. DEPRESSION AND ANXIETY
- Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders
- (2013) Michael E. Benros et al. JAMA Psychiatry
- Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
- (2012) Seyed-Hesameddin Abbasi et al. JOURNAL OF AFFECTIVE DISORDERS
- Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial
- (2012) Khatereh Sepanjnia et al. NEUROPSYCHOPHARMACOLOGY
- Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study
- (2012) Tsuyoshi Miyaoka et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial
- (2011) Cynthia Fields et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept
- (2011) S. Tyring et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- TNF-α Antagonist Infliximab in the Treatment of Depression in Older Adults
- (2010) D. Willemijn Maas et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
- (2010) Richard G. Langley et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial
- (2010) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial
- (2009) J Kekow et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
- (2009) Shahin Akhondzadeh et al. DEPRESSION AND ANXIETY
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
- (2009) M Bryant Howren et al. PSYCHOSOMATIC MEDICINE
- Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial
- (2008) Edward V. Loftus et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started